FDA approves 1st rapid-acting insulin
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
prosecutors said Court TV/YouTube A former West Virginia pharmacist was convicted of killing her husband of 19 years by injecting him with insulin — all to keep him from finding out about a $2 ...
Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...
A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.
Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by a near-total absence of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results